During a live event, Thomas G. Martin, MD, discussed the importance of controlling disease and avoiding barriers to access so patients with multiple myeloma can receive CAR T-cell therapy.

Nasal nanodrops carrying gold-based spherical nucleic acids can slip into the brain and activate powerful immune pathways ...

This academic-industry partnership reflects the need for a multidisciplinary approach to innovation in cell and gene therapy manufacturing.

Studying T cells, the immune cells most responsible for responding to infections and cancers, just received a significant ...

Ribosomes don’t just make proteins—they can sense when something’s wrong. When they collide, they send out stress signals ...

Blocking a single protein revs up T cells, boosting their energy reserves and helping them fight tumors longer in new mouse ...

Researchers had developed ways to trigger an immune reaction against these tumours by stimulating a pathway within cells ...

A new nasal-delivered nanotherapy shows promise against aggressive glioblastoma tumors. By activating the STING immune ...

Immunotherapy has transformed cancer treatment, but persistent challenges, such as T cell exhaustion, limited persistence, and variability in response, continue to impact therapeutic success ...

This important study describes a deep learning framework that analyzes single-cell RNA data to identify a tumor-agnostic gene signature associated with brain metastases. The identified signature ...

Citius Oncology, Inc. ("Citius Oncology") (Nasdaq: CTOR), the oncology-focused subsidiary of Citius Pharmaceuticals, Inc. ("Citius Pharma") (Nasdaq: CTXR), a late-stage biopharmaceutical company ...

Researchers at WashU Medicine have developed a noninvasive medicine delivered through the nose that successfully eliminated ...